Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewThe European Union Pharmaceutical Legislation proposal jeopardizes biotechnological innova...
This is evident in the study conducted by EuropaBio, titled "Impact of the General Pharmaceutical Legislation of the European Union on the Innovation Ecosystem and Biotechnological Companies in Europe
-
Press releaseThe European Union Pharmaceutical Legislation proposal jeopardizes biotechnological innova...
This is evident in the study conducted by EuropaBio, titled "Impact of the General Pharmaceutical Legislation of the European Union on the Innovation Ecosystem and Biotechnological Companies in Europe
-
NewThe Ministry of Health presents the new Common Catalog of Genetic and Genomic Tests of the...
The catalog, which currently includes 672 tests, will continue to be progressively expanded due to its 'flexible' nature, with the commitment to ensure more homogeneous and equitable access to these
-
NewAseBio joins the open letter addressed to Members of the European Parliament regarding the...
The letter is supported by 35 Nobel laureates and over 1,000 scientists, urging the European Parliament to unlock the use of New Genomic Techniques in agriculture.
-
-
AllyBALDER
We are an industrial property law firm with more than 90 professionals, including 15 European Patent Attorneys. Our principal goal is to provide the highest quality legal services possible through our
-
NewFDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for...
PreveCol®, a blood test for oncological diagnosis, has obtained US recognition for its efficacy in detecting precancerous lesions compared to existing alternatives in the United States.
-
AllyCBRE ESPAÑA
Headquarted in Dallas and listed on the NYSE, Fortune 500 and S&P 500, CBRE Group is the world´s leading real estate consulting and services company (based on fiscal 2022 revenues). It has more than
-
CompanyAFARVI SISTEMAS
-
EventZETA SYMPOSIUM 2024
-
New#NewMemberAseBio | “AseBio is the meeting place for Spanish development and progress in th...
Meet BIOXYTOL, our new member. We talked its with Kamaljit S. Sood, CEO.
-
New#NewAseBioMember | "AseBio has established a unique platform for the exchange of knowledge...
Meet THYTECH, our new member. We talked to its Rafael Correa-Rocha, Director & Co-Founder.
-
NewORYZON to Host KOL Event on Phase IIb PORTICO Topline Study Results of Vafidemstat in Bord...
The event will feature a brief review of the topline results of the Phase IIb PORTICO study, then a discussion with experts.
-
NewThe third edition of the AseBio Forum – TERAV – Ciber on advanced therapies analyzes the c...
The technical meeting and collaborative forum have been held under the title "Applications of non-viral vectors in gene editing and therapy: Challenges for academia and industry."
-
Press releaseThe third edition of the AseBio Forum – TERAV – Ciber on advanced therapies analyzes the c...
The technical meeting and collaborative forum have been held under the title "Applications of non-viral vectors in gene editing and therapy: Challenges for academia and industry." More than 30
-
-
-
EventSLAS Europe Sales
-
-
EventKnowledge for Growth
-
EventVitafoods Europe